Neurodegenerative Disease Market - Forecast(2022 - 2027)

1
Neurodegenerative Disease MarketMarket size,
Industry outlook, Market Forecast, Demand
Analysis, Market Share, Market Report 2021-2026
Contact Venkat Reddy sales_at_industryarc.com
(1) 970-236-3677
2
Download PDF Brochure

• The Neurodegenerative Disease Market size is
  estimated to reach 49,218 million by 2027.
  Furthermore, it is poised to grow at a CAGR of
  3.9 over the forecast period of 2022-2027.
  Neurodegenerative diseases are a set of brain
  disorders that cause the structure and function
  of neurons in the central nervous system (CNS)
  and peripheral nervous system (PNS) to
  deteriorate over time (PNS). Several drugs are
  currently available to help people lessen
  physical or mental symptoms and improve their
  quality of life. Furthermore, researchers are
  concentrating their efforts on developing
  molecular diagnostics, particularly biomarkers
  and imaging spectroscopy, in order to detect and
  diagnose neurodegenerative illnesses at an early
  stage and halt their progression.

Inquiry Before Buying
Email sales_at_industryarc.com
3
Download PDF Brochure
Download PDF Brochure

• Key Takeaways
• Geographically, North America held a dominant
  market share in the year 2021. The growing
  geriatric population in the US is increasing the
  prevalence of neurodegenerative diseases as age
  is the best known risk factor for such diseases.
  The geriatric population was estimated to be
  around 65 million in 2020. This is projected to
  increase by 18 million between 2020 and 2030 and
  it is estimated that approximately 1 in every 5
  Americans will be 65 or more by 2030..
• The surge in neurodegenerative diseases in the US
  owing to the rising geriatric population is
  increasing the demand for effective
  neurodegenerative disease therapies for treating
  the disease and suppressing symptoms.

Inquiry Before Buying
Email sales_at_industryarc.com
4


Download PDF Brochure
By Distribution Channel- Segment Analysis The
neurodegenerative disease market based on drug
class can be further segmented into
N-Methyl-D-Aspartate (NMDA) Receptor Antagonists,
Acetylcholinesterase (AChE) Inhibitors, Dopamine
Agonists and Antagonist, Monoamine Oxidase B
(MAO-B) Inhibitor, Catechol-O-Methyltransferase
(COMT) Inhibitor. Immunomodulators held a
dominant market share in the year 2021.
Immunomodulators provides very effective therapy
options for a variety of autoimmune and
neurodegenerative illnesses. Furthermore, the
growing presence of important companies is likely
to raise patient and physician awareness of the
benefits of immunomodulators. 
Inquiry Before Buying
Email sales_at_industryarc.com
5


Download PDF Brochure

• Neurodegenerative Disease Market Industry
  Outlook 
• Biogen Inc.,
• F. Hoffman La Roche Ltd.,
• Merck KGaA,
• Novartis AG,
• Sanofi,
• Teva Pharmaceuticals Industries Ltd.,
• Orion Corporation,
• H. Lundbeck A/S.,
• Sun Pharmaceutical Industries Ltd.,
• UCB S.A.

Inquiry Before Buying
Email sales_at_industryarc.com
6
Download PDF Brochure
Neurodegenerative Disease Market -
Forecast(2022 - 2027) Learn
More About the Report
_at_ https//www.industryarc.com/Report/16
074/neurodegenerative-disease-market.html
Inquiry Before Buying
Email sales_at_industryarc.com
7
Download PDF Brochure

• You Can Customize the Report as Per Your Need.
  We have included Some Customization Options
• Company Profile
• Analyst Briefing
• Data Tables
• Key Contacts
• Free Customization
• Purchase Full Report _at_ https//www.industryarc.com
  /purchasereport.php?id16074

Inquiry Before Buying
Email sales_at_industryarc.com
8
Download PDF Brochure
For More Details Contact Venkat
Reddy Contact (1) 970-236-3677 Email
sales_at_industryarc.com Connect with us on LinkedIn
_at_ http//www.linkedin.com/company/industryarc
Contact (1) 970-236-3677
Inquiry Before Buying
Email sales_at_industryarc.com